PHAR (Pharming Group) Float Percentage Of Total Shares Outstanding: 99.36% (As of Jul. 01, 2026)


PHAR Pharming Group PHAR
76 GF Score
Price $13.89
GF Value $14.64
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Pharming Group Float Percentage Of Total Shares Outstanding?

Pharming Group PHAR +3.73% 76 Float Percentage Of Total Shares Outstanding is 99.36% as of Jul. 01, 2026. GuruFocus rates PHAR with a GF Score™ of 76/100 and a GF Value™ of $14.64 (Fairly Valued). The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pharming Group's float shares is 70.18 Mil. Pharming Group's total shares outstanding is 70.63 Mil. Pharming Group's float percentage of total shares outstanding is 99.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pharming Group's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pharming Group's Institutional Ownership is 0.12%.

PHAR
76GF Score
Pharming Group PHAR
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharming Group Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Pharming Group's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=70.18/70.63
=99.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.36% mean?
Pharming Group (PHAR) has a Float Percentage Of Total Shares Outstanding of 99.36% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Pharming Group and its competitors.
Is Pharming Group's Float Percentage Of Total Shares Outstanding too high?
Pharming Group's current Float Percentage Of Total Shares Outstanding is 99.36%. Overall, Pharming Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharming Group's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Pharming Group's Float Percentage Of Total Shares Outstanding of 99.36% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Pharming Group and its competitors. Pharming Group's current Float Percentage Of Total Shares Outstanding is 99.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharming Group stock overvalued right now?
Based on GuruFocus' analysis, Pharming Group (PHAR) is currently considered Fairly Valued. The stock's GF Value™ is $14.64, compared to a current price of $13.89 — trading 5.1% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.36%. Pharming Group's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Pharming Group (PHAR), the current Float Percentage Of Total Shares Outstanding is 99.36% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharming Group (PHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharming Group stock appears to be undervalued. The current stock price of $13.89 is trading 5.1% below its estimated GF Value™ of $14.64. GuruFocus considers Pharming Group to be Fairly Valued.

Key valuation signals for PHAR:

  • Float Percentage Of Total Shares Outstanding: 99.36%
  • GF Value™: $14.64 vs. price of $13.89 (5.1% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the PHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharming Group Business Description

Address Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
76GF Score

Get the complete analysis for PHAR

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.89
Price
$14.64
GF Value